Augmedix (OTCMKTS:AUGX) Stock Price Up 0.4%

Shares of Augmedix, Inc. (OTCMKTS:AUGX) were up 0.4% on Friday . The company traded as high as $2.34 and last traded at $2.34. Approximately 167,430 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 657,957 shares. The stock had previously closed at $2.33.

Augmedix Stock Performance

The stock has a market capitalization of $114.59 million, a PE ratio of -5.44 and a beta of -0.22. The business’s fifty day moving average is $2.18 and its two-hundred day moving average is $2.24. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 3.74.

Augmedix (OTCMKTS:AUGX) last released its earnings results on Monday, August 12th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.04). The company had revenue of $13.66 million for the quarter, compared to the consensus estimate of $13.68 million. Augmedix had a negative net margin of 57.70% and a negative return on equity of 980.09%. As a group, research analysts anticipate that Augmedix, Inc. will post -0.48 EPS for the current fiscal year.

Augmedix Company Profile

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.